Cardiopulmonary Bypass Copolymer Surface Modification Reduces neither Blood Loss nor Transfusions in Coronary Artery Surgery
Bibliographic record
Abstract
All articles of this category We read with interest the recent publication by Südkamp et al. concerning the efficacy of a cardiopulmonary bypass (CPB) copolymer surface in modulating blood loss and transfusion requirements in low-risk cardiac surgery patients [ 1 ]. We and others have previously demonstrated that this surface (SMAR x T™, Sorin Biomedical) has intrinsic thromboresistant properties; however, in our relatively small trial, no clinical benefits were detected [ 2 ]. In Südkamp's randomized controlled trial, blood loss and transfusion requirements were identical between the groups (SMAR x T™ and control), and the authors concluded that this surface “does not appear to improve clinical outcome”. We believe that these results are misleading since the trial design obscured the ability to detect the benefit of this surface. It is unfortunate that aprotinin was administered to both groups, as it is entirely probable that the antifibrinolytic and platelet-sparing effects of SMA surfaces are identical to those of aprotinin [ 3 ] [ 4 ] [ 5 ]. Although aprotinin's use is commonplace, its use in low-risk coronary cases is not supported; thus, a trial design excluding this drug would have been ethically and scientifically sound. Therefore, all the authors can conclude is that the use of SMA surfaces confer no additional benefit to aprotinin therapy regarding bleeding and transfusion requirements. Future approaches to improving the outcome with CPB will likely involve a combination of an optimized biocompatible surface coupled with a complementary pharmaceutical agent. It now becomes the clinical scientist's responsibility to design the trials to pair off these options.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.010 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.002 | 0.003 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".